JMP Securities Reaffirms "Market Outperform" Rating for Athira Pharma (NASDAQ:ATHA)
JMP Securities reiterated their market outperform rating on shares of Athira Pharma (NASDAQ:ATHA – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $19.00 price target on the stock. Athira Pharma Price Performance Athira Pharma stock opened at $2.52 on Thursday. The stock’s 50 day moving average is […]